• The Academy has a profound duty to its members, the larger medical community and the public to ensure the integrity of all of its scientific, educational, advocacy and consumer information activities and materials. Thus each Academy Trustee, Secretary, committee Chair, committee member, taskforce chair, taskforce member, councilor, and representative to other organizations (“Academy Leader”), as well as the Academy staff and those responsible for organizing and presenting CME activities must disclose interactions with Companies and manage conflicts of interest or the appearance of conflicts of interest that affect this integrity. Where such conflicts or perceived conflicts exist, they must be appropriately and fully disclosed and resolved.

    All contributors to Academy educational and leadership activities must disclose all financial relationships (defined below) to the Academy annually. The ACCME requires the Academy to disclose the following to participants prior to the activity:

    • All financial relationships with Commercial Companies that contributors and their immediate family have had within the previous 12 months. A commercial company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
    • Meeting presenters, authors, contributors or reviewers who report they have no known financial relationships to disclose.

    The Academy will request disclosure information from meeting presenters, authors, contributors or reviewers, committee members, Board of Trustees, and others involved in Academy leadership activities (“Contributors”) annually. Disclosure information will be kept on file and used during the calendar year in which it was collected for all Academy activities. Updates to the disclosure information file should be made whenever there is a change. At the time of submission of a Journal article or materials for an educational activity or nomination to a leadership position, each Contributor should specifically review his/her statement on file and notify the Academy of any changes to his/her financial disclosures. These requirements apply to relationships that are in place at the time of or were in place 12 months preceding the presentation, publication submission, or nomination to a leadership position. Any financial relationship that may constitute a conflict of interest will be resolved prior to the delivery of the activity.

    Financial Relationship Disclosure

    For purposes of this disclosure, a known financial relationship is defined as any financial gain or expectancy of financial gain brought to the Contributor or the Contributor’s immediate family (defined as spouse, domestic partner, parent, child or spouse of child, or sibling or spouse of sibling of the Contributor) by:

    • Direct or indirect compensation;
    • Ownership of stock in the producing company;
    • Stock options and/or warrants in the producing company, even if they have not been exercised or they are not currently exercisable;
    • Financial support or funding to the investigator, including research support from government agencies (e.g., NIH), device manufacturers, and\or pharmaceutical companies; or
    • Involvement with any for-profit corporation that is likely to become involved in activities directly impacting the Academy where the Contributor or the Contributor’s family is a director or recipient of a grant from said entity, including consultant fees, honoraria, and funded travel.

    Description of Financial Interests

    Consultant / Advisor C Consultant fee, paid advisory boards or fees for attending a meeting.
    Employee E Employed by or received a W2 from a commercial company.
    Lecture Fees L Lecture fees or honoraria, travel fees or reimbursements when speaking at the invitation of a commercial company.
    Equity / Stock Owner O Equity ownership/stock options in publicly or privately traded firms, excluding mutual funds.
    Patents / Royalty P Patents and/or royalties for intellectual property.
    Grant Support S Grant support or other financial support to the investigator from all sources, including research support from government agencies (e.g., NIH), foundations, device manufacturers, and\or pharmaceutical companies.

    Secretary for Annual Meeting

    Name Disclosure
    Maria M Aaron MD None

    Annual Meeting Program Committee

    The Annual Meeting Program Committee is responsible for the Academy's annual meeting Scientific Program, including Instruction Courses, Symposia, the Spotlight on Cataract, Scientific Papers/ePosters and Videos. Each subcommittee has five - ten reviewers who grade the instruction courses and paper/e-poster abstracts as well as three subcommittee members who review the grades, then select the courses and abstracts for presentation.

    Associate Secretary for the Annual Meeting Program Disclosure
    Bennie H Jeng MD EyeGate Pharmaceuticals Inc.: O; GlaxoSmithKline: C; Kedrion: C; Merck & Co. Inc.: C
    Annual Meeting Program Committee
    Nicole R Fram MD Alcon Laboratories Inc.: CL; Allergan: C; Bausch + Lomb: L; CorneaGen: CO; Dompé: CL; Johnson & Johnson Vision: CL; Novartis Pharma AG: L; Ocular Science: CO; Sun Pharmaceutical: L
    Jessica B Ciralsky MD Bruder Healthcare Company: C
    Steven J Gedde MD None
    Andrew G Lee MD Horizon Therapeutics: C
    Julian D. Perry, MD None
    Martha P Schatz MD None
    Ronald R Krueger MD Alcon Laboratories Inc.: C; Bausch + Lomb: C; Johnson & Johnson Vision: C; Ocutrx: OC; Optoquest: C; Rx Sight: O; Strathespey Crown: O
    Sharon D Solomon MD None

    Subcommittee for: Cataract

    Chair Disclosure
    Nicole R Fram MD Alcon Laboratories Inc.: CL; Allergan: C; Bausch + Lomb: L; CorneaGen: CO; Dompé: CL; Johnson & Johnson Vision: CL; Novartis Pharma AG: L; Ocular Science: CO; Sun Pharmaceutical: L
    Subcommittee Members
    Surendra Basti MBBS Bausch + Lomb: C; Johnson & Johnson Vision: C
    Sathish Srinivasan MBBS AcuFocus Inc.: C; Alcon Laboratories Inc.: C; Bausch Lomb: C; DORC International bv/Dutch Ophthalmic USA: C; Medicontur: C; Scope Ophthalmics: C; THEA: L
    Subcommittee Reviewers
    Brandon Ayres MD Alcon Laboratories Inc.: CL; Allergan: CL; Bausch+Lomb: L; Carl Zeiss Meditec: C; CorneaGen: C; Dompe: CL; New World Medical Inc: C; Novartis Alcon Pharmaceuticals: C; omeros: C; Tear Lab: C
    Kourtney A Houser MD Alcon: L; Avellino Labs: C; Bausch and Lomb: C; CorneaGen: L
    Jeremy Z Kieval MD Dompe: C; Johnson & Johnson: CL; Kala: CL; Novartis Pharma AG: C; Ocular Therapeutix: C; Sun Ophthalmics: C: Takeda: CL
    Susan M MacDonald MD PERFECT LENS: C;O
    Steven M Naids MD Allergan Inc.: C; Bausch + Lomb: L; Eyevance: C

    Subcommittee for: Cornea, External Disease

    Chair Disclosure
    Jessica B Ciralsky MD Bruder Healthcare Company: C
    Subcommittee Members
    Jennifer Y Li MD None
    Elmer Y Tu MD Dompe: C; Eversight: ES: Eye Bank Association of America: S; Kedrion: C; Okogen: C
    Subcommittee Reviewers
    Vatinee Y Bunya MD Bausch + Lomb: S; Celularity Inc: C; Verily: C; Allergan: C; Bio-Tissue Inc.: C; CorneaGen: C; Dompe: C; Eyepoint: C; Eyevance: C; Johnson & Johnson: C
    Marjan Farid MD Vision; C; KALA: C; Novartis: C; Alcon Pharmaceuticals: C
    Asim V Farooq MD GlaxoSmithKline: C
    Anat Galor MD Allergan: C; Dompe: C; Novaliq: C; Shire: C
    Jennifer R Rose-Nussbaumer MD None

    Subcommittee for: Glaucoma

    Chair Disclosure
    Steven J Gedde MD None
    Members
    Paula Anne Newman-Casey MD None
    Brian C Samuels MD PhD None
    Subcommittee Reviewers
    Jenny Chen MD None
    Shane J Havens MD Aerie Pharmaceuticals Inc.: CL; Perrigo: S
    Veena Rao MD None
    Sarah Van Tassel MD Allergan Inc.: C; New World Medical Inc: L

    Subcommittee for: Neuro-Ophthalmology, Electronic Health Records/Information Technology, Ethics, General Medical, Global Ophthalmology, Medical Education, Ophthalmic History and Vision Rehabilitation

    Chair Disclosure
    Andrew G Lee MD horizon: C
    Members
    Julie Falardeau MD None
    Kenneth S Shindler MD PhD FM Kirby Foundation: S; National Eye Institute: S; Noveome Biotherapeutics Inc.: CS; RPB: S; UpToDate: P
    Reviewers
    Shauna E Berry DO None
    John J Chen MD PhD None
    Courtney E Francis MD None
    Susan M Ksiazek MD None
    Y Joyce Liao MD PhD None

    Subcommittee for: Ocular Pathology, Oncology and Oculoplastics, Orbit

    Chair Disclosure
    Julian D Perry None
    Members
    Jonathan W Kim MD None
    Sara T Wester MD Horizon Therapeutics: C
    Reviewers
    Malena M Amato MD None
    Steven M Couch MD None
    Bradford William Lee MD MSC Horizon Pharmaceuticals: O
    Lily Koo Lin MD Horizon Pharmaceuticals: C

    Subcommittee for: Pediatric Ophthalmology, Strabismus

    Chair Disclosure
    Martha P Schatz MD None
    Members
    Stacy L Pineles MD None
    Federico G Velez MD Luminopia: S; Nevakar: C
    Reviewers
    Kara M Cavuoto MD None
    Aaron D Grant MD None
    Tina Rutar MD Sydnexis: S
    Erin D Stahl MD Avedro Inc.: C; Nevakar: C; Treehouse Health: CO
    Mitchell B Strominger MD None

    Subcommittee for: Optics, Refraction, Contact Lenses, and Refractive Sugery

    Chair Disclosure
    Ronald R Krueger MD Alcon Laboratories Inc.: C; Bausch + Lomb: C; Johnson & Johnson Vision: C; Ocutrx: OC; Optoquest: C; Rx Sight: O; Strathespey Crown: O
    Members
    J Bradley Randleman MD None
    Elizabeth Yeu MD Alcon Laboratories Inc.: CL; Allergan: CL; ArcScan: C; Bausch + Lomb: C; Bausch Lomb: C; Bio-Tissue Inc.: CL; Carl Zeiss Meditec: CL; Glaukos Corporation: CL; Innovation Labs: O; iOptics: CS; Johnson & Johnson Vision: CL; Kala: CS; Katena Products Inc: C; Modernizing Medicine: O; Novartis Alcon Pharmaceuticals: C; Ocular Science: CO; OcuSoft: C; Omeros: L; ScienceBased Health: C; Shire: CL; Sight Sciences: C; Sun Ophthalmics: L; TearLab: C; TearScience: C; TissueTech Inc.: CL; Topcon Medical Systems Inc.: S
    Reviewers
    Kathryn Masselam Hatch MD Carl Zeiss Meditec: C; EyePoint: C; EyeVance: C; Glaukos Corporation: CO; Johnson & Johnson Vision: C
    Brad E Kligman MD None
    Edward E Manche MD Alcon Laboratories Inc.: S; Allergan: S; Averdro: CS; Best Doctors Inc.: C; Carl Zeiss Inc: CS; Guidepoint: C; Johnson & Johnson Vision: CS; Ocular Therapeutix: S; Placid0 INc: O; Presbia Inc.: S; RxSight: O; Vacu-Site: OP
    Jodhbir S Mehta MBBS PhD None
    Roger Zaldivar MD AcuFocus Inc.: C; Johnson & Johnson: C; oculentis: C; PhysIOL sa: C; ZEISS: C

    Subcommittee for: Retina, Vitreous and Uveitis, Intraocular Inflammation

    Chair Disclosure
    Sharon D Solomon MD None
    Members
    Anita Agarwal MD None
    Sunir J Garg MD FACS Aerpio: S; Allergan Inc.: S; apellis: S; Bausch+Lomb: C; Deciphera: C; EyeGate Pharmaceuticals Inc.: S; Johnson & Johnson: C; Nexttech: O; Topivert: C
    Reviewers
    Roomasa Channa MD None
    Jay K Chhablani MBBS Allergan Inc.: L; Novartis Pharma AG: L; OD-OS GmbH: S
    Adam S Wenick MD None
    Alice Zhang MD None
    Muge R Kesen MD None
    Stephen J Kim MD None
    Jaclyn L Kovach MD Novartis Pharma AG: L; Regeneron Pharmaceuticals Inc.: L
    Aleksandra V Rachitskaya MD Alcon Laboratories Inc.: C; Allergan: C; Novartis Pharma AG: L; Zeiss: C
    Amy C Schefler MD Allergan: C; Aura Biosciences: SC; Castle Biosciences: SC; GENENTECH: CS; Regeneron Pharmaceuticals Inc.: S

    Special Projects Committee

    The Special Projects Committee is responsible for developing programming and formats that cross subspecialties, as well as complement those that are submitted by members or societies.

    Associate Secretary Disclosure
    Florentino E Palmon MD None
    Members
    Daniel H Chang MD AcuFocus Inc.: S; Allergan: CS; Carl Zeiss Meditec: CL; Johnson & Johnson Vision: CLS; Mynosys Cellular Devices: CS; Omega Ophthalmics: CO
    Laura B Enyedi MD Nevakar; C
    Collin M McClelland MD Horizon Therapeutics: C
    Carolyn K Pan MD Prescient Surgical: PO
    Rachel K Sobel MD None
    Sarah Wellik MD None

    Skills Transfer Advisory Committee

    The Skills Transfer Advisory Committee is responsible for selecting the Skills Transfer courses and labs.

    Associate Secretary Disclosure
    Jack A Cohen MD FACS None
    Members
    Cat Burkat MD FACS Horizon Pharma: C
    Deepinder K Dhaliwal MD Avedro, Inc.: S; CorneaGen: L; Johnson & Johnson: C; Noveome: S; Ocular Therapeutix: L; STAAR Surgical: L; Trefoil: C
    Brian A Francis MD Aerie Pharmaceuticals, Inc.: C; Allergan, Inc.: C,S; Bausch + Lomb: C; Diopsys: C,S; Endo Optiks, Inc.: C; Glaukos Corporation: C; MicroSurgical Technology: C; NeoMedix Corporation: C
    Sumit Garg MD Aerie Pharmaceuticals, Inc.: C; Alcon Laboratories, Inc.: C; Allergan, Inc.: C; Dompe: C; EyePoint: C; Glaukos Corporation: C; Johnson & Johnson Vision: C; Kala: C; LensGen: C,O; New World Medical Inc: C; Novartis, Alcon Pharmaceuticals: C; OcuTrx: O; SightLife Surgical: C; SightSciences: C; Tarsus: C; Verana Health: C; Vision Care Inc.: C; Zeiss: C
    Michael L Savitt MD None
    Anjali Tannan MD None

    2020 Subspecialty Day Advisory Committee

    Associate Secretary Disclosure
    R Michael Siatkowski MD National Eye Institute: S
    Members
    Bonnie An Henderson MD Alcon Laboratories, Inc.: C,L; EyePoint: C; Novartis Pharma AG: C; Zeiss: C
    Julia A Haller MD Aura Biosciences: C; Bionic Sight LLC: C; Bristol Myers Squibb: O; KalVista: C; Lowy Medical Research Institute: C; Novartis Pharmaceuticals Corporation: C
    Michael S Lee MD evolvemed: C; horizon: O; springer: P; uptodate: P; vindico: C
    Shahzad I Mian MD Centrasight: S; National Eye Institute: S
    Kuldev Singh MD Aerpio: C; Alcon Laboratories, Inc.: C; Allergan: C; Belkin Laser Ltd: C; Glaukos Corporation: C; Graybug: C; InjectSense: C; Ivantis: C; Johnson & Johnson: C; Mynosys: C; National Eye Institute: S; Novartis Pharma AG: C; Ocular Therapeutix, Inc.: C; Oculis: C; Radiance Therapeutics: C; Regenexbio: C; Santen, Inc.: C; Sight Sciences, Inc.: C; Thieme Medical Publishers: C; U.S. Food and Drug Administration: C,S

    2020 Subspecialty Day Program Directors

    Cornea

    Sanjay V Patel MD FRCOphth GlaxoSmithKline: C;
    Santen, Inc.: C;
    Senju Pharmaceutical Co.,Ltd.: C
    Sophie X Deng MD PhD California Institute for Regenerative Medicine: S;
    Dompe Inc: C;
    F-Prime: C;
    Kowa Research Institute, Inc: C;
    National Eye Institute: S;
    W. L. Gore & associates: C
    Vishal Jhanji MD None

    Glaucoma

    Eydie G Miller-Ellis MD Aerie Pharmaceuticals, Inc.: C;
    Allergan: C,S;
    Eyenovia: C;
    National Eye Institute: S;
    THEA: C
    Brian A Francis MD Aerie Pharmaceuticals, Inc.: C;
    Allergan, Inc.: C,S;
    Bausch + Lomb: C;
    Diopsys: C,S;
    Endo Optiks, Inc.: C;
    Glaukos Corporation: C;
    MicroSurgical Technology: C;
    NeoMedix Corporation: C
    Lama A Al-Aswad MD MPH Aerie Pharmaceuticals, Inc.: C;
    GlobeChek: O;
    New World Medical Inc: S;
    Save Vision Foundation: S;
    Topcon Medical Systems Inc.: S
    Edward M Barnett MD PhD None
    Donald L Budenz MD MPH iView: C;
    New World Medical Inc: L;
    Nicox: C
    Teresa C Chen MD Department of Defense: S;
    Harvard Foundation Grant (Fidelity Charitable Fund): S
    Vikas Chopra MD Alcon Laboratories, Inc.: C;
    Allergan: C,S
    Ian Patrick Conner MD PhD Ivantis: C;
    Ocugenix: C,O,P
    Ronald Leigh Fellman MD OCS Aerie Pharmaceuticals, Inc.: L;
    Alcon Laboratories, Inc.: C;
    Bausch + Lomb: L;
    Endo Optiks, Inc.: C;
    InnFocus: S
    Annette L Giangiacomo MD None
    Davinder S Grover MD MPH Aerie Pharmaceuticals, Inc.: L;
    Allergan: C,L,S;
    Bausch + Lomb: L,C;
    Glaukos Corporation: C;
    MicroOptx: C;
    New World Medical Inc: C,L;
    Reichert, Inc.: C,L
    Leon W Herndon Jr MD None
    Dale K Heuer MD Alcon Laboratories, Inc: A,C;
    Allergan, Inc: A,C;
    Merck U.S. Human Health: C;
    Pfizer Ophthalmics: A,C
    Albert S Khouri MD Aerie Pharmaceuticals: C,L;
    Allergan: L,S;
    Bausch + Lomb: L;
    Glaukos Corporation: C;
    New Jersey Health Foundation: S;
    Optovue: S
    Christine LeeAnn Larsen MD Aerie Pharmaceuticals, Inc.: L;
    Allergan, Inc.: C
    John T Lind MD Aerie Pharmaceuticals, Inc.: C,L;
    Perrigo: S

    Ocular Oncology/Pathology

    Dan S Gombos MD Children's Oncolog: S;
    Houseman/Wilkins Ophthalmological Foundation: S;
    Lois Kuss Fund for Glaucoma: S
    Paul J Bryar MD None

    Oculofacial Plastic Surgery

    Jeremiah P Tao MD Horizon Therapeutics: C
    Catherine J Hwang MD None

    Pediatric Ophthalmology

    Michael F Chiang MD GENENTECH: S;
    Inteleretina: O;
    National Eye Institute: S;
    National Science Foundation: S;
    Novartis Pharmaceuticals Corporation: C
    Gena Heidary MD Children's Tumor Foundation: S;
    National Eye Institute: S
    Gil Binenbaum MD Luminopia: C, O;
    National Eye Institute: S;
    Natus Medical Incorporated: L;
    x Biomedical: O, P
    Jeffrey S Hunter MD None
    Scott A Larson MD None
    David G Morrison MD Regeneron Pharmaceuticals, Inc.: S
    Stacy L Pineles MD None
    Deborah K VanderVeen MD OPHTEC: S; Retrophin: S

    Refractive Surgery

    George O Waring IV MD ACE Vision: C;
    AcuFocus, Inc.: C,L;
    Alcon Laboratories, Inc.: C,L;
    Allergan: C,L;
    Allotex: C;
    Avedro: C,L;
    Bausch Lomb: C,L;
    GlassesOff: C;
    Glaukos Corporation: C,L;
    Ivantis: C;
    Johnson & Johnson Vision: C,L;
    novartis: C;
    Oculus, Inc.: C,L;
    Omega Ophthalmics: C;
    Omeros: C;
    OptoQuest: C;
    Perfect Lens, LLC: C;
    Refocus Group, Inc.: C;
    Riechert: C;
    Shire: C;
    Sight Sciences, Inc.: C;
    SRD Vision: C;
    Strasthpey Crown: O;
    Visiometrics: C,O;
    Zepto: C
    Burkhard Dick MD Avedro, Inc.: C;
    Bausch + Lomb: L;
    Johnson & Johnson Vision: C;
    Johnson & Johnson: L;
    Oculus Surgical, Inc.: P;
    RxSight Inc.: C
    Renato Ambrosio Jr MD Alcon Laboratories, Inc.: C;
    Allergan: L;
    Carl Zeiss Inc: L;
    Essilor Instruments: L;
    Mediphacos: L;
    Oculus, Inc.: C
    Bonnie Henderson MD Alcon Laboratories, Inc.: C,L;
    EyePoint: C;
    Novartis Pharma AG: C;
    Zeiss: C
    J Bradley Randleman, MD None
    Marcony R Santhiago MD Alcon Laboratories, Inc.: C,L;
    ziemer: C

    Retina

    Judy E Kim MD Adverum: C;
    Alimera Sciences, Inc.: C;
    Allergan: C;
    cellcure: C;
    Clearside: C;
    Eyepoint: C;
    GENENTECH: C;
    Kodiak: C;
    Notal Vision, Inc.: S;
    Notal Vision: C;
    Novartis: L;
    Optos, Inc.: S
    Mark W Johnson MD Amgen: C;
    Apellis: S;
    Aura Biosciences: C;
    Pfizer, Inc.: C;
    Syneos Health: C
    John S Pollack MD Aldeyra: S;
    Allergan, Inc.: C;
    Covalent Medical: O;
    DORC International, bv/Dutch Ophthalmic, USA: C;
    GENENTECH: C,S;
    Graybug: C;
    jCyte: C;
    Notal Vision, Inc.: C,O;
    PRIME Education: C;
    Regeneron Pharmaceuticals, Inc.: C;
    REGENXBIO: C;
    Santen: C;
    Vestrum Health: O
    Srinivas R Sadda MD 4DMT: C;
    Allergan: C;
    Amgen: C;
    Carl Zeiss Meditec: C,S;
    Centervue: C;
    GENENTECH: C;
    Heidelberg Engineering: C,L,S;
    Merck & Co., Inc.: C;
    Nidek: L;
    Novartis Pharma AG: C,L;
    Optos, Inc.: C;
    Regeneron Pharmaceuticals, Inc.: C;
    ThromboGenics, Inc.: C;
    Topcon Medical Systems Inc.: L

    Uveitis

    Hatice N Sen MD None
    Nisha Acharya MD National Eye Institute: S
    Sapna Gangaputra MBBS None
    John A Gonzales MD Kaiser Permanente: L;
    National Eye Institute: S
    Alan Gary Palestine MD None
    Kathryn L Pepple MD PhD National Eye Institute: S
    Lucia Sobrin MD Novartis: C

    2020 AAOE Content Committee

    The AAOE Annual Meeting Program Committee is responsible for selecting the AAOE Instruction Courses, Coding Sessions and the Practice Management Master Classes.

    Chair Disclosure
    Natalie M Loyacano COMT ROUB OSA OCSR (F)ATPO None
    Vice-Chair
    Ann M Hulett CMPE None
    AAOE Senior Secretary for Practice Management
    Ravi D Goel MD None
    Members
    Stephanie Mangham Collins MBA COA OCSR Regeneron Pharmaceuticals, Inc.: C,L
    Brett D Gerwin MD None
    Sean D Goodale CPA MBA GENENTECH: C,L; Novartis Pharma AG: C; Regeneron: C,L
    Anthony Pruett Johnson MD FACS None
    Nicole E Kesten MS None
    Julia Lee JD Modernizing Medicine: C
    Heather Modjesky COE None

    Academy Staff

    Name Disclosure
    Debra Rosencrance None
    Melanie Rafaty None
    Sangeeta Fernandes None
    Susan Oslar None
    Ann L'Estrange None
    Elizabeth Washburn None
    Licia Wells None
    Julia Fennell None
    Sadie Peckens None